Stay updated on VELIA Clinical Trial: Veliparib in Ovarian Cancer
Sign up to get notified when there's something new on the VELIA Clinical Trial: Veliparib in Ovarian Cancer page.

Latest updates to the VELIA Clinical Trial: Veliparib in Ovarian Cancer page
- Check5 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2. No substantive changes to the study record or its presentation.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added and the previous v3.4.1 revision plus a government funding status notice were removed. This update does not alter core study details or page content.SummaryDifference0.1%

- Check41 days agoChange DetectedA government funding lapse notice with operation-status information was added, and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check48 days agoChange DetectedIntroduces a Show glossary option and a Revision: v3.4.0 tag, and updates labels for QC criteria and the No FEAR Act notice with capitalization tweaks.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision: v3.3.4 is now shown, replacing the previous Revision: v3.3.3.SummaryDifference0.0%

- Check84 days agoChange DetectedThe page's Locations section has been expanded to include a large number of sites across multiple regions, broadening geographic coverage for the study.SummaryDifference2%

Stay in the know with updates to VELIA Clinical Trial: Veliparib in Ovarian Cancer
Enter your email address, and we'll notify you when there's something new on the VELIA Clinical Trial: Veliparib in Ovarian Cancer page.